These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7682523)

  • 21. Chromatographic methods for the determination of therapeutic oligonucleotides.
    McGinnis AC; Chen B; Bartlett MG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():76-94. PubMed ID: 21945211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligonucleotide therapies for disorders of the nervous system.
    Khorkova O; Wahlestedt C
    Nat Biotechnol; 2017 Mar; 35(3):249-263. PubMed ID: 28244991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines and therapeutic oligonucleotides.
    Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern approaches to therapeutic oligonucleotide manufacturing.
    Obexer R; Nassir M; Moody ER; Baran PS; Lovelock SL
    Science; 2024 Apr; 384(6692):eadl4015. PubMed ID: 38603508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards Improved Oligonucleotide Therapeutics Through Faster Target Binding Kinetics.
    Menzi M; Wild B; Pradère U; Malinowska AL; Brunschweiger A; Lightfoot HL; Hall J
    Chemistry; 2017 Oct; 23(57):14221-14230. PubMed ID: 28746731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular uptake and intracellular trafficking of oligonucleotides.
    Juliano RL; Carver K
    Adv Drug Deliv Rev; 2015 Jun; 87():35-45. PubMed ID: 25881722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic oligonucleotides with polyethylene glycol modifications.
    Winkler J
    Future Med Chem; 2015; 7(13):1721-31. PubMed ID: 26465713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory considerations for oligonucleotide drugs: updated recommendations for pharmacology and toxicology studies.
    Black LE; Farrelly JG; Cavagnaro JA; Ahn CH; DeGeorge JJ; Taylor AS; DeFelice AF; Jordan A
    Antisense Res Dev; 1994; 4(4):299-301. PubMed ID: 7734946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two sides of the coin: affinity and specificity of nucleic acid interactions.
    Demidov VV; Frank-Kamenetskii MD
    Trends Biochem Sci; 2004 Feb; 29(2):62-71. PubMed ID: 15102432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human therapeutics based on triple helix technology.
    Chubb JM; Hogan ME
    Trends Biotechnol; 1992 Apr; 10(4):132-6. PubMed ID: 1374262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational screening of oligonucleotide combinatorial libraries for drug discovery.
    Ecker DJ; Vickers TA; Hanecak R; Driver V; Anderson K
    Nucleic Acids Res; 1993 Apr; 21(8):1853-6. PubMed ID: 7684128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dynamics simulation and binding energy calculation for estimation of oligonucleotide duplex thermostability in RNA-based therapeutics.
    Shen L; Johnson TL; Clugston S; Huang H; Butenhof KJ; Stanton RV
    J Chem Inf Model; 2011 Aug; 51(8):1957-65. PubMed ID: 21702481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleic acid binding properties of thyminyl and adeninyl pyrrolidine-amide oligonucleotide mimics (POM).
    Tan TH; Hickman DT; Morral J; Beadham IG; Micklefield J
    Chem Commun (Camb); 2004 Mar; (5):516-7. PubMed ID: 14973585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular oligonucleotides: new concepts in oligonucleotide design.
    Kool ET
    Annu Rev Biophys Biomol Struct; 1996; 25():1-28. PubMed ID: 8800462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and antifungal activity of oligonucleotides in Candida albicans.
    Disney MD; Haidaris CG; Turner DH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1530-4. PubMed ID: 12552085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scaffolding along nucleic acid duplexes using 2'-amino-locked nucleic acids.
    Astakhova IK; Wengel J
    Acc Chem Res; 2014 Jun; 47(6):1768-77. PubMed ID: 24749544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.